SINGULAR HEALTH GROUP LTD — Proxy Solicitation & Information Statement 2021

Apr 5, 2021

==> picture [132 x 37] intentionally omitted <==

ASX Release: SHG

Singular Health Group Limited - General Meeting

Notice is hereby given that a General Meeting of the Shareholders of Singular Health Group Limited (ASX: SHG) ( Company ) will be held at the offices of the Company at 3/26 Railway Road, Subiaco WA 6008 on Tuesday, 11 May 2021 at 10am (WST) ( Meeting ).

The Board has made the decision that it will hold a physical Meeting with the appropriate social gathering and physical distancing measures in place to comply with the Federal Government’s and State Government’s current restrictions for physical gatherings.

Further in accordance with the now ceased Corporations (Coronavirus Economic Response) Determination (No. 3) 2020 ( Determination ), Treasury Laws Amendment (2021 Measures (No. 1) Bill 2021 ( Bill ) and ASIC’s ‘no-action’ position published on 29 March 2021 supporting (amongst other things) the convening of meetings using electronic notice of meetings as was permitted under the Determination and as is proposed under the Bill, the Company will not be dispatching physical copies of the notice of Meeting ( Notice ). Instead, a - copy of the Notice can be viewed and downloaded online at https://singular.health/investor centre/.

If you have not elected to receive notices from the Company by email, a copy of your personalised proxy form will be sent to you by mail enclosed with this letter.

Shareholders are encouraged to submit proxy votes either online at https://investor.automic.com.au/#/home or by returning (where applicable) the enclosed proxy form as per the options below:

By post to: Singular Health Group Limited C/- Automic Group GPO Box 5193 SYDNEY NSW 2001 By facsimile to: +61 2 8583 3040 By email: meetings@automicgroup.com.au

Your proxy voting instruction must be received by 10am (WST) on Sunday, 9 May 2021 being not less than 48 hours before the commencement of the Meeting. Any proxy voting instructions received after that time will not be valid for the Meeting.

==> picture [596 x 114] intentionally omitted <==

==> picture [154 x 43] intentionally omitted <==

The situation regarding COVID-19 is constantly evolving and accordingly, the Company may make alternative arrangements to the way in which the Meeting is held. If this occurs, we will notify any changes by way of an announcement on ASX and the details will also be made available on our website.

Accordingly, the Board encourages shareholders to monitor the Company's website for any updates in relation to the Meeting that may need to be provided. In the meantime, the Board encourages shareholders to submit their proxies as early as possible, even if they intend to attend the meeting in person, as the situation may change (e.g. shareholders may be restricted from travelling or there may be restrictions on how the meeting itself may be held or conducted).

The Notice is important and should be read in its entirety. If you are in doubt as to the course of action you should follow, you should consult your financial adviser, lawyer, accountant or other professional adviser.

If you have any difficulties accessing the Notice please contact the Company’s share registry, Automic Registry Services on 1300 288 664 or + 61 2 9698 5414.

Authorised for release by the Company Secretary.

Ends.

Contacts

Corporate Investor Media Steven Wood James Hill Jane Morgan Company Secretary +61 413 825 646 +61 405 555 618 sw@grangeconsulting.com.au jhill@singular.health jm@janemorganmanagement.com.au

Follow the Company developments through our website and social media channels Website https://singular.health/ Twitter https://twitter.com/Singular_Health LinkedIn https://www.linkedin.com/company/singularhealth/

==> picture [596 x 30] intentionally omitted <==

ASX: SHG | www.singular.health

2